Applications of artificial intelligence in prostate cancer care: a path to enhanced efficiency and outcomes
The landscape of prostate cancer care has rapidly evolved. We have transitioned from the
use of conventional imaging, radical surgeries, and single-agent androgen deprivation …
use of conventional imaging, radical surgeries, and single-agent androgen deprivation …
Management of prostate cancer in older adults
The majority of men with prostate cancer are diagnosed when they are older than 65 years;
however, clinical trial participants are disproportionately younger and more fit than the real …
however, clinical trial participants are disproportionately younger and more fit than the real …
Differences in health professionals' engagement with electronic health records based on inpatient race and ethnicity
Importance US health professionals devote a large amount of effort to engaging with
patients' electronic health records (EHRs) to deliver care. It is unknown whether patients with …
patients' electronic health records (EHRs) to deliver care. It is unknown whether patients with …
A systematic review of family history, race/ethnicity, and genetic risk on prostate cancer detection and outcomes: considerations in PSA-based screening
NJ Graham, LH Souter, SS Salami - Urologic Oncology: Seminars and …, 2024 - Elsevier
Aim To investigate the role of family history, race/ethnicity, and genetics in prostate cancer
(PCa) screening. Methods We conducted a systematic review of articles from January 2013 …
(PCa) screening. Methods We conducted a systematic review of articles from January 2013 …
Equitable access to clinical trials: how do we achieve it?
A Acuña-Villaorduña, JC Baranda… - American Society of …, 2023 - ascopubs.org
The mismatch between the study populations participating in oncology clinical trials and the
composition of the targeted cancer population requires urgent amelioration. Regulatory …
composition of the targeted cancer population requires urgent amelioration. Regulatory …
Stockholm3 in a multiethnic cohort for prostate cancer detection (SEPTA): A prospective multicentered trial
PURPOSE Asian, Black, and Hispanic men are underrepresented in prostate cancer (PCa)
clinical trials. Few novel prostate cancer biomarkers have been validated in diverse cohorts …
clinical trials. Few novel prostate cancer biomarkers have been validated in diverse cohorts …
PARP-ish: gaps in molecular understanding and clinical trials targeting PARP exacerbate racial disparities in prostate cancer
ML Cunningham, MJ Schiewer - Cancer Research, 2024 - aacrjournals.org
PARP is a nuclear enzyme with a major function in the DNA damage response. PARP
inhibitors (PARPi) have been developed for treating tumors harboring homologous …
inhibitors (PARPi) have been developed for treating tumors harboring homologous …
Symptom burden and follow-up of patients with neck and back complaints in specialized outpatient care: a national register study
Back and neck pain are common in the population, especially among immigrants. In
Norway's specialist care system, treating these patients typically involves a multidisciplinary …
Norway's specialist care system, treating these patients typically involves a multidisciplinary …
Impact of Asian race on prognosis in de novo metastatic prostate cancer
Background: Little is known about the impact of Asian race on the long-term survival
outcomes of males with de novo metastatic prostate cancer (PCa). Understanding racial …
outcomes of males with de novo metastatic prostate cancer (PCa). Understanding racial …
[HTML][HTML] Clinical outcomes of enzalutamide in metastatic hormone-sensitive prostate cancer in patients aged< 75 and≥ 75 years: ARCHES post hoc analysis
F Gomez-Veiga, RZ Szmulewitz, J Holzbeierlein… - European Urology …, 2024 - Elsevier
Background In ARCHES, treatment intensification of androgen deprivation therapy (ADT)
with enzalutamide versus placebo improved clinical outcomes in metastatic hormone …
with enzalutamide versus placebo improved clinical outcomes in metastatic hormone …